Assignee
SUNOVION PHARMACEUTICALS INC
US·91 granted patents·58 pending applications·252 citations·filing 2006–2023
Top patents by PatentIndex Score
149 records- 0197US10874639B2Nonracemic mixtures and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Dec 29, 2020·8 cites·30 claims
- 0297US10660875B1Nonracemic mixtures and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted May 26, 2020·10 cites·24 claims
- 0397US10377708B2Crystal forms and production methods thereofSUNOVION PHARMACEUTICALS INC·Filed 2018·Granted Aug 13, 2019·13 cites·22 claims
- 0496US11370753B2Crystal forms and production methods thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Jun 28, 2022·5 cites·12 claims
- 0596US10577317B2Crystal forms and production methods thereofSUNOVION PHARMACEUTICALS INC·Filed 2019·Granted Mar 3, 2020·10 cites·42 claims
- 0695US10894033B2Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Jan 19, 2021·3 cites·21 claims
- 0795US10369134B2Nonracemic mixtures and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2018·Granted Aug 6, 2019·14 cites·29 claims
- 0895US10285953B2Sublingual filmsSUNOVION PHARMACEUTICALS INC·Filed 2016·Granted May 14, 2019·17 cites·22 claims
- 0994US10576058B2Nonracemic mixtures and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2019·Granted Mar 3, 2020·10 cites·6 claims
- 1093US11517558B2Nonracemic mixtures and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Dec 6, 2022·2 cites·20 claims
- 1193US11440921B2Salts, crystal forms, and production methods thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Sep 13, 2022·3 cites·21 claims
- 1292US11654113B2Modified release formulations and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2021·Granted May 23, 2023·3 cites·24 claims
- 1392US11160758B2Modified release formulations and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Nov 2, 2021·6 cites·29 claims
- 1492US10815249B2Salts, crystal forms, and production methods thereofSUNOVION PHARMACEUTICALS INC·Filed 2019·Granted Oct 27, 2020·6 cites·44 claims
- 1592US10800738B2Crystal forms and production methods thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Oct 13, 2020·3 cites·70 claims
- 1691US10196403B2Compounds and compositions and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 5, 2019·8 cites·44 claims
- 1791US10085968B2Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2015·Granted Oct 2, 2018·7 cites·60 claims
- 1891US9669019B2Sublingual apomorphineSUNOVION PHARMACEUTICALS INC·Filed 2015·Granted Jun 6, 2017·6 cites·31 claims
- 1991US9669021B2Sublingual apomorphineSUNOVION PHARMACEUTICALS INC·Filed 2015·Granted Jun 6, 2017·6 cites·22 claims
- 2091US9351954B2Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted May 31, 2016·10 cites·37 claims
- 2191US8053603B2Tetralone-based monoamine reuptake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2006·Granted Nov 8, 2011·24 cites·23 claims
- 2290US11767293B2Crystal forms and production methods thereofSUNOVION PHARMACEUTICALS INC·Filed 2022·Granted Sep 26, 2023·1 cites·12 claims
- 2389US11129807B2Methods of treating schizophreniaSUNOVION PHARMACEUTICALS INC·Filed 2018·Granted Sep 28, 2021·5 cites·22 claims
- 2489US10336732B21-heterocyclyl isochromanyl compounds and analogs for treating CNS disordersSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Jul 2, 2019·7 cites·20 claims
- 2589US9669018B2Sublingual apomorphineSUNOVION PHARMACEUTICALS INC·Filed 2015·Granted Jun 6, 2017·5 cites·29 claims
- 2689US9669020B2Sublingual apomorphineSUNOVION PHARMACEUTICALS INC·Filed 2015·Granted Jun 6, 2017·5 cites·26 claims
- 2788US10420763B2Sublingual apomorphineSUNOVION PHARMACEUTICALS INC·Filed 2018·Granted Sep 24, 2019·3 cites·13 claims
- 2887US11491133B2Heteroaryl-isochroman compounds and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Nov 8, 2022·2 cites·57 claims
- 2987US9249162B2Substituted [1,2,4]triazolo[1,5-a]pyridines as PDE-10 inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted Feb 2, 2016·7 cites·27 claims
- 3086US10562916B2Substituted quinoxalines as PDE-10 inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 18, 2020·4 cites·24 claims
- 3186US10449146B2Methods of treating parkinson's disease by administration of apomorphine to an oral mucosaSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Oct 22, 2019·2 cites·13 claims
- 3286US9072699B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted Jul 7, 2015·4 cites·6 claims
- 3384US12161623B2Nonracemic mixtures and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2022·Granted Dec 10, 2024·0 cites·15 claims
- 3483US10959943B2Methods of treating Parkinson's disease by administration of apomorphine to an oral mucosaSUNOVION PHARMACEUTICALS INC·Filed 2019·Granted Mar 30, 2021·1 cites·52 claims
- 3583US8344030B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineSUNOVION PHARMACEUTICALS INC·Filed 2012·Granted Jan 1, 2013·3 cites·6 claims
- 3682US10815042B2Easy-open peel pouchSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Oct 27, 2020·6 cites·15 claims
- 3782US10702486B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamineSUNOVION PHARMACEUTICALS INC·Filed 2019·Granted Jul 7, 2020·0 cites·6 claims
- 3881US11738002B2Methods of treating neurological and psychiatric disordersSUNOVION PHARMACEUTICALS INC·Filed 2021·Granted Aug 29, 2023·1 cites·21 claims
- 3981US11136304B2Salts of a heterocyclic compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Oct 5, 2021·1 cites·22 claims
- 4081US10556890B2Heteroaryl compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 11, 2020·2 cites·14 claims
- 4181US9758529B2Fused dihydro-4H-pyrazolo[5,1-C][1,4]oxazinyl compounds and analogs for treating CNS disordersSUNOVION PHARMACEUTICALS INC·Filed 2016·Granted Sep 12, 2017·3 cites·54 claims
- 4280US10780074B2Compounds and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2018·Granted Sep 22, 2020·2 cites·55 claims
- 4380US8754117B2Pyrrolidine triple reuptake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2013·Granted Jun 17, 2014·3 cites·26 claims
- 4480US7964753B2Formoterol tartrate process and polymorphSUNOVION PHARMACEUTICALS INC·Filed 2010·Granted Jun 21, 2011·2 cites·3 claims
- 4580US2022387382A1Multicyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4679US9856238B21-heterocyclyl isochromanyl compounds and analogs for treating CNS disordersSUNOVION PHARMACEUTICALS INC·Filed 2016·Granted Jan 2, 2018·2 cites·33 claims
- 4779US9040588B2Acetamide stereoisomerSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted May 26, 2015·1 cites·15 claims
- 4878US9133117B2Triple reuptake inhibitors and methods of their useSUNOVION PHARMACEUTICALS INC·Filed 2013·Granted Sep 15, 2015·2 cites·21 claims
- 4978US2020030315A1Sublingual apomorphineSUNOVION PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 5077US2021046021A1TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINESUNOVION PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
Showing the top 50 of 149 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →